Solventum SOLV MedSurg — Depreciation expense

Similar metrics at other companies

NDSNMedical and Fluid Solutions — Depreciation

$7.83M-9.7%

IR

IRMedical — D&A

$5.63M-4.3%

NDSNMedical Fluid Systems — Depreciation, Depletion and Amortization

$3.01M-6.6%

MEDPReportable Segment — Depreciation

$6.75M+0.9%

ENTGMS — Total depreciation

$14.2M-36.6%

SYKMedSurg and Neurotechnology: — Capital Expenditures During Period

$58M+75.8%

Questions, answered.

What is Solventum's medsurg — depreciation expense?

Solventum (SOLV) reported medsurg — depreciation expense of $32.75M in Q4 2025.

How has Solventum's medsurg — depreciation expense changed year-over-year?

Solventum's medsurg — depreciation expense increased by 6.5% year-over-year, from $30.75M to $32.75M.

What is the long-term trend for Solventum's medsurg — depreciation expense?

Over 3 years (2022 to 2025), Solventum's medsurg — depreciation expense has grown at a -3.1% compound annual growth rate (CAGR), from $144M to $131M.

What does medsurg — depreciation expense mean?

The non-cash cost representing the wear and tear of MedSurg physical assets.

How do you interpret medsurg — depreciation expense?

High depreciation relative to assets may indicate an aging asset base, while stable levels suggest consistent capital investment.

How does medsurg — depreciation expense compare across companies?

Standard non-cash expense metric for capital-intensive manufacturing segments.